REGISTERED NUMBER: 12005918 (England and Wales)

UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 MAY 2025

FOR

SDG VASCULAR LTD

Page

Statement of Financial Position

1

Notes to the Financial Statements

2

FIXED ASSETS

Tangible assets

4

4,471

6,674

CURRENT ASSETS

Debtors

5

23,037

11,538

Cash at bank

2,400

28,504

25,437

40,042

CREDITORS

Amounts falling due within one year

6

2,058

4,018

NET CURRENT ASSETS

23,379

36,024

TOTAL ASSETS LESS CURRENT LIABILITIES

27,850

42,698

PROVISIONS FOR LIABILITIES

7

1,118

1,268

NET ASSETS

26,732

41,430

CAPITAL AND RESERVES

Called up share capital

8

2

2

Retained earnings

26,730

41,428

SHAREHOLDERS' FUNDS

26,732

41,430

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 May 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 May 2025 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:

(a)	ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b)

preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Statement of Income and Retained Earnings has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 24 October 2025 and were signed on its behalf by:

Dr S D Goode - Director

1.	STATUTORY INFORMATION

SDG Vascular Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address are as below:

Registered number:

12005918

Registered office:

Ground Floor

H5 Ash Tree Court

Nottingham Business Park

Nottingham

Nottinghamshire

NG8 6PY

2.	ACCOUNTING POLICIES

Basis of preparing the financial statements

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover

Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets

Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Plant and machinery etc

-

33% on reducing balance

Taxation

Taxation for the year comprises current and deferred tax. Tax is recognised in the Statement of Income and Retained Earnings, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the statement of financial position date.

Deferred tax

Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the statement of financial position date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

3.	EMPLOYEES AND DIRECTORS

The average number of employees during the year was 2 (2024 - 2 ) .

4.	TANGIBLE FIXED ASSETS

Plant and

machinery

etc

£

COST

At 1 June 2024

and 31 May 2025

16,829

DEPRECIATION

At 1 June 2024

10,155

Charge for year

2,203

At 31 May 2025

12,358

NET BOOK VALUE

At 31 May 2025

4,471

At 31 May 2024

6,674

5.

DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

31/5/25

31/5/24

£

£

Trade debtors

6,200

-

Other debtors

16,837

11,538

23,037

11,538

6.

CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

31/5/25

31/5/24

£

£

Taxation and social security

-

1,488

Other creditors

2,058

2,530

2,058

4,018

7.	PROVISIONS FOR LIABILITIES

31/5/25

31/5/24

£

£

Deferred tax

Accelerated capital allowances

1,118

1,268

Deferred

tax

£

Balance at 1 June 2024

1,268

Provided during year

(150

)

Balance at 31 May 2025

1,118

8.	CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:

Number:

Class:

Nominal

31/5/25

31/5/24

value:

£

£

2

Ordinary

£1

2

2